Analytik Jena with Significant Sales Increase after First Half of Financial Year
(Thomson Reuters ONE) -
Analytik Jena AG /
Analytik Jena with Significant Sales Increase after First Half of Financial Year
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* Earnings influenced by natural disaster in Japan and weak US dollar
* Outlook for financial year: sales and earnings increase
Jena (Germany), May 12, 2011 - Analytik Jena AG (Prime Standard: AJA, ISIN:
DE0005213508) again significantly increased its sales. After six months, the
Group generated sales of EUR 44.5 m, up 9.0 % on the previous year. This was
announced today by the manufacturer of analytical measuring technology, life
science instruments and optoelectronics at the presentation of the semi-annual
figures in Jena.
Sales Development and Segments
The sales increase was generated in all three business units, but mostly came
from Analytical Instrumentation. In its core business Analytik Jena posted
group-wide EUR 27.7 m (previous year: EUR 24.4 m) after six months, 13.7 % more
than in the first half of 2009/2010. Analytical Instrumentation continued to
benefit from the strong market position in Asia and has thus again increased
incoming orders on these key markets. After a slight decline in the first
quarter, the growth division Life Science with sales of EUR 14.3 m (previous
year: EUR 14.0 m) after six months posted a sales increase of 2.2 % as against
the previous year. Developments proved stable in the consumer division of
Optics, which saw growth of 1.0 % on the previous year with sales of EUR 2.4 m
(previous year: EUR 2.4 m).
Earnings
Overall, Analytik Jena's earnings were down on the previous year's level. EBITDA
amounted to EUR 4.5 m (previous year: EUR 4.7 m), therefore down 5.5 %. EBIT was
also lower on account of the strong rise in selling and administrative expenses
compared to sales and amounted to EUR 2.6 m (previous year: EUR 3.0 m). The
Company achieved an EBIT margin of 5.9 %. While Analytik Jena's pre-tax earnings
in the previous year had benefited from the favorable currency situation, this
year they were impacted by the development of the US dollar and the Japanese
yen, and were therefore down by 59.9 %. Earnings before taxes (EBT) amounted to
EUR 1.1 m (previous year: EUR 2.8 m).
In the reporting period, Analytik Jena achieved a total net profit of EUR 0.8 m
(previous year: EUR 2.0 m), 59.9 % less than in the previous year. This is equal
to earnings per share of EUR 0.13 (previous year: EUR 0.37).
Changes in Statement of Financial Position
The Group's total assets fell slightly by 0.2 % from EUR 83.6 m (September
30, 2010) to EUR 83.4 m as of March 31, 2011. In the reporting period, Analytik
Jena reported equity of EUR 40.4 m (September 30, 2010: EUR 39.0 m). This
corresponds to an equity ratio of 48.4 %. The Group's cash and cash equivalents
amounted to EUR 8.2 m as of the end of the reporting period.
Human Resources
As at the balance sheet date as of March 31, 2011, the Group employed 800 staff,
of which 39 trainees (previous year: 776 employees, including 45 trainees).
Outlook
The Executive Board of Analytik Jena is projecting sales of around EUR 86.0 m to
EUR 89.0 m and EBIT of between EUR 4.5 m and EUR 5.5 m for the current financial
year.
"We aim for further growth in all three divisions. The biggest challenge will be
compensating for the losses in Japan. Furthermore, the effects of the weak US
dollar also have to be countered", says Klaus Berka, CEO of Analytik Jena AG.
Looking at the individual divisions, the Company is forecasting a stable
performance in its core area of Analytical Instrumentation in the second half of
2010/2011 as well. The Life Science segment is expected to enjoy growing market
success due to the new real-time PCR products coupled with stable profitable
developments at the CyBio and Biometra subsidiaries. The anticipated
stabilization of Optics business will be strengthened by significantly higher
incoming orders from the IWA trade fair at the start of March, which will be
recognized in sales over the course of the financial year.
The full financial report can be accessed at http://berichte.analytik-jena.de/6-
MonthReport_1011.pdf.
Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena/Germany
Tel. +49 3641 779281
Email: ir(at)analytik-jena.com
--- End of Message ---
Analytik Jena AG
Konrad-Zuse-Straße 1 Jena Germany
WKN: 521350 ;ISIN: DE0005213508;Index:Prime All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Analytik Jena AG via Thomson Reuters ONE
[HUG#1514893]
Unternehmensinformation / Kurzprofil:
Datum: 12.05.2011 - 07:03 Uhr
Sprache: Deutsch
News-ID 54562
Anzahl Zeichen: 5984
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 157 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Analytik Jena with Significant Sales Increase after First Half of Financial Year"
steht unter der journalistisch-redaktionellen Verantwortung von
Analytik Jena AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
